{"brief_title": "Phase 2 Study of TLK286 in Metastatic Breast Cancer", "brief_summary": "The purpose of this study is to determine the effectiveness of TLK286 in treatment of metastatic breast cancer.", "condition": ["Breast Neoplasms"], "intervention_type": ["Drug"], "intervention_name": ["TLK286"], "criteria": "Inclusion Criteria: - Histologic diagnosis of breast cancer - Metastatic disease - Measurable or evaluable disease - No prior chemotherapy regimens - Age at least 18 years - Adequate liver and kidney function - Adequate bone marrow function Exclusion Criteria: - Pregnant or lactating women - Unstable medical conditions - Chemotherapy within 14 days of TLK286 - Radiation therapy within 14 days of TLK286 - Hormonal therapy within 14 days of TLK286 - Immunotherapy within 14 days of TLK286 - CNS metastasis unless controlled by treatment", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "mesh_term": ["Breast Neoplasms"], "id": "NCT00035841"}